Surgical and short-term oncological safety of total neoadjuvant therapy in high-risk locally advanced rectal cancer.

TNT is clinically safe in high-risk LARC patients with no significant difference to surgical and short-term oncological outcomes compared to LCCRT, although a higher incidence of early surgical morbidity was observed.